Working… Menu

MPN-RC 118 AVID200 in Myelofibrosis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03895112
Recruitment Status : Recruiting
First Posted : March 29, 2019
Last Update Posted : June 2, 2020
Formation Biologics
National Cancer Institute (NCI)
Myeloproliferative Neoplasm Research Consortium (MPN-RC)
Information provided by (Responsible Party):
John Mascarenhas, Icahn School of Medicine at Mount Sinai

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : March 2021
Estimated Study Completion Date : March 2023